Advertisement
Document › Details
Biognosys AG. (9/16/11). "Press Release: iRT Concept Is Gaining Acceptance. Biognosys Is Invited to Present Its iRT Concept for Mass Spectrometry Specialists".
![]() |
Region | Reinach BL |
| Country | Switzerland | |
![]() |
Organisation | Biognosys AG |
| Organisation 2 | Thermo Fisher (Group) | |
![]() |
Product | RT-Kit (Biognosys) |
| Product 2 | TSQ Vantage LC/MS system | |
On September, 29th Biognosys is invited to present its iRT concept at the "Mass Spectrometry in Biological Sciences" seminar in Basel organized by Thermo Fisher Scientific. The concept of normalized retention time (iRT) allows proteomics researchers to easily schedule multiplexed MRM experiments with high accuracy in the prediction of peptide retention times, resulting in increased overall sensitivity. Biognosys developed the RT-Kit that, in combination with Thermo Fishers "on-the-fly retention time shift correction" TSQ Vantage system, significantly improves analytical robustness and throughput of MRM measurements. This seminar is a great platform to share Biognosys' expertise and experience with other researches working in the field of MRM proteomics.
For free registration to the seminar "Mass Spectrometry in Biological Sciences" in Basel (Reinach), on September 29th, click here >>
[ http://event1.thermoscientific.com/forms/SID_LSMSEuroTour_E302_1110_SE-CM-PH_MS808 ]
Record changed: 2011-11-25 |
More documents for Biognosys AG
- [1] [iito] Business Intelligence. (3/13/12). "[MSC] Newsletter February 2012". Bremen....
- [2] Biognosys AG. (2/16/12). "Press Release: Skyline, the Most Popular Software for Targeted Proteomics Integrates Now iRT"....
- [3] Biognosys AG. (1/3/12). "Press Release: Biognosys and ETH Zurich Receive CHF 1.5m Funding from CTI"....
- [4] Biognosys AG. (12/7/11). "Press Release: Biognosys Collaborates with M2 to Develop Commercial MRM Software"....
- [5] Biognosys AG. (10/31/11). "Press Release: Biognosys Raises CHF 2.7m in Series A Financing. Biognosys Attracted Venture Capital from Experienced Investors including Syngenta Ventures"....
- [6] Biognosys AG. (9/9/11). "Press Release: Biognosys Celebrates 3rd Anniversary. On September 9th, 2011, Biognosys Turns 3 Years Old..."....
- [7] Biognosys AG. (8/4/11). "Press Release: Meet Biognosys at HUPO / Geneva. Biognosys AG Is Participating in the 10th Annual World Congress of the Human Proteome Organisation in Geneva"....
- [8] Biognosys AG. (7/4/11). "Press Release: Deal with Novartis Vaccines and Diagnostics. Siena, Italy – Biognosys Is Entering into a Collaboration with Novartis Vaccines and Diagnostics"....
- [9] Biognosys AG. (5/24/11). "Press Release: MRMbase.com. The World’s Most Validated Library of Mass Spec Assays"....
- [10] Biognosys AG. (5/24/11). "Press Release: Biognosys at ASMS / Denver"....
To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com
» top
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spectrometry-portal-logo.jpg)








![Banner [iiito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)